Metropolitan Life Insurance Company Upped Its Summit Midstream Partners Units (SMLP) Position by $970,000 as Stock Price Declined; Berkley W R Has Decreased Its Stake in Healthequity (HQY) by $43.31 Million

May 28, 2018 - By Dolores Ford

HealthEquity, Inc. (NASDAQ:HQY) Logo

Metropolitan Life Insurance Company increased its stake in Summit Midstream Partners Units (SMLP) by 60.36% based on its latest 2017Q4 regulatory filing with the SEC. Metropolitan Life Insurance Company bought 48,500 shares as the company’s stock declined 32.20% with the market. The institutional investor held 128,855 shares of the public utilities company at the end of 2017Q4, valued at $2.64 million, up from 80,355 at the end of the previous reported quarter. Metropolitan Life Insurance Company who had been investing in Summit Midstream Partners Units for a number of months, seems to be bullish on the $1.19 billion market cap company. The stock increased 0.95% or $0.15 during the last trading session, reaching $15.9. About 150,567 shares traded. Summit Midstream Partners, LP (NYSE:SMLP) has declined 38.73% since May 28, 2017 and is downtrending. It has underperformed by 50.28% the S&P500.

Berkley W R Corp decreased its stake in Healthequity Inc (HQY) by 12.82% based on its latest 2017Q4 regulatory filing with the SEC. Berkley W R Corp sold 941,616 shares as the company’s stock rose 26.48% while stock markets declined. The institutional investor held 6.40 million shares of the miscellaneous company at the end of 2017Q4, valued at $298.84 million, down from 7.35M at the end of the previous reported quarter. Berkley W R Corp who had been investing in Healthequity Inc for a number of months, seems to be less bullish one the $4.75B market cap company. The stock increased 1.62% or $1.23 during the last trading session, reaching $76.94. About 300,377 shares traded. HealthEquity, Inc. (NASDAQ:HQY) has risen 49.52% since May 28, 2017 and is uptrending. It has outperformed by 37.97% the S&P500.

More news for Summit Midstream Partners, LP (NYSE:SMLP) were recently published by: Prnewswire.com, which released: “Summit Midstream Partners, LP Announces Series A Preferred Distribution” on May 25, 2018. Seekingalpha.com‘s article titled: “Q1’18 MLP Distribution Recap: Several Growers Overshadowed By 2 Cuts” and published on May 23, 2018 is yet another important article.

Investors sentiment increased to 1.24 in Q4 2017. Its up 0.41, from 0.83 in 2017Q3. It improved, as 8 investors sold SMLP shares while 17 reduced holdings. 12 funds opened positions while 19 raised stakes. 36.88 million shares or 3.16% more from 35.75 million shares in 2017Q3 were reported. Emory University holds 1.54% in Summit Midstream Partners, LP (NYSE:SMLP) or 87,560 shares. 360,800 are held by Evergreen Capital Management. Citadel Limited Liability Co holds 11,685 shares. 205,000 are held by Prudential Public Limited Company. Rafferty Asset Mgmt Ltd invested 0.04% in Summit Midstream Partners, LP (NYSE:SMLP). Commonwealth Of Pennsylvania School Empls Retrmt Sys reported 615,271 shares stake. Goldman Sachs Grp Inc accumulated 668,684 shares or 0% of the stock. Clearbridge Limited Liability Company reported 753,610 shares. Deutsche Bank & Trust Ag reported 0% in Summit Midstream Partners, LP (NYSE:SMLP). First Tru Advsrs LP reported 0.02% in Summit Midstream Partners, LP (NYSE:SMLP). Metropolitan Life Insurance Ny invested 0.04% in Summit Midstream Partners, LP (NYSE:SMLP). Moreover, Royal Bankshares Of Canada has 0% invested in Summit Midstream Partners, LP (NYSE:SMLP). Kayne Anderson Cap LP has 3.33 million shares for 0.87% of their portfolio. Raymond James Svcs owns 10,300 shares. Van Eck Associate Corp holds 0% or 45,509 shares.

Among 10 analysts covering Summit Midstream Partners (NYSE:SMLP), 3 have Buy rating, 1 Sell and 6 Hold. Therefore 30% are positive. Summit Midstream Partners had 37 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Summit Midstream Partners, LP (NYSE:SMLP) has “Outperform” rating given on Wednesday, January 11 by Wells Fargo. The stock has “Neutral” rating by Citigroup on Thursday, March 10. As per Friday, January 15, the company rating was downgraded by Wells Fargo. The rating was maintained by Robert W. Baird with “Outperform” on Friday, August 11. On Monday, June 5 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock of Summit Midstream Partners, LP (NYSE:SMLP) earned “Buy” rating by Robert W. Baird on Wednesday, September 20. The rating was downgraded by Credit Suisse to “Neutral” on Friday, January 27. SunTrust maintained Summit Midstream Partners, LP (NYSE:SMLP) rating on Monday, March 5. SunTrust has “Hold” rating and $19.0 target. The stock of Summit Midstream Partners, LP (NYSE:SMLP) has “Hold” rating given on Monday, May 7 by Wells Fargo. The firm has “Outperform” rating given on Tuesday, September 6 by RBC Capital Markets.

Metropolitan Life Insurance Company, which manages about $14.10B and $7.53B US Long portfolio, decreased its stake in Helmerich & Payne Inc (NYSE:HP) by 34,734 shares to 16,745 shares, valued at $1.08M in 2017Q4, according to the filing. It also reduced its holding in Dycom Industries Inc (NYSE:DY) by 31,610 shares in the quarter, leaving it with 17,293 shares, and cut its stake in Hp Inc.

Since March 9, 2018, it had 1 insider purchase, and 4 selling transactions for $4,971 activity. Another trade for 1,000 shares valued at $14,550 was made by Matthews Louise E on Monday, March 19. Newby Steven J also bought $238,200 worth of Summit Midstream Partners, LP (NYSE:SMLP) shares.

Among 16 analysts covering HealthEquity Inc (NASDAQ:HQY), 14 have Buy rating, 0 Sell and 2 Hold. Therefore 88% are positive. HealthEquity Inc had 45 analyst reports since August 18, 2015 according to SRatingsIntel. The stock of HealthEquity, Inc. (NASDAQ:HQY) earned “Buy” rating by J.P. Morgan on Tuesday, April 24. The stock has “Hold” rating by Robert W. Baird on Tuesday, September 19. The firm earned “Buy” rating on Wednesday, June 7 by Cantor Fitzgerald. The rating was maintained by SunTrust on Wednesday, June 8 with “Buy”. Oppenheimer maintained the stock with “Outperform” rating in Tuesday, March 20 report. The rating was maintained by Chardan Capital Markets on Wednesday, March 22 with “Buy”. Raymond James maintained HealthEquity, Inc. (NASDAQ:HQY) on Friday, December 15 with “Buy” rating. The firm earned “Buy” rating on Thursday, July 13 by Cantor Fitzgerald. The stock of HealthEquity, Inc. (NASDAQ:HQY) has “Hold” rating given on Tuesday, October 13 by TheStreet. The firm has “Buy” rating given on Monday, March 26 by Oppenheimer.

More news for HealthEquity, Inc. (NASDAQ:HQY) were recently published by: Nasdaq.com, which released: “HealthEquity Sets Date to Announce First Quarter Results Fiscal Year 2019” on May 14, 2018. Seekingalpha.com‘s article titled: “Premarket analyst action – healthcare” and published on May 23, 2018 is yet another important article.

Summit Midstream Partners, LP (NYSE:SMLP) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>